Last 12 months
Inside the activity.
10 purchase rows · 4 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 2 | 0 |
| Feb 2026 | 0 | 2 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 6 | 2 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 2 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| October 06, 2025 Filed Oct 8, 2025 21:41 UTC |
Jones Mitchell LawrenceChief Medical Officer
|
GrantRestricted Stock Units · Derivative | 7,665,800 | $0.00 | $0.00 |
DisclosureSEC source: 0001493152-25-017477 · ownership.xml · derivative · entry 1 Jones Mitchell Lawrence · CIK 0001993292 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,665,800 Underlying: Common Stock · 7,665,800 shares Expires not disclosed F1 · derivative.exercise_price: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Issuer's common stock, provided that, until such time as the Issuer has sufficient shares of Issuer common stock reserved under its 2021 Equity Incentive Plan to issue upon settlement of all outstanding grants thereunder, the RSUs may be settled upon vesting in cash. F2 · derivative.exercise_date: The RSUs shall vest with respect to 1/3rd of the shares on October 6, 2026 and quarterly thereafter over the following eight quarters, subject to the Reporting Person's continuous service to the Issuer through each such vesting date. F2 · derivative.expiration_date: The RSUs shall vest with respect to 1/3rd of the shares on October 6, 2026 and quarterly thereafter over the following eight quarters, subject to the Reporting Person's continuous service to the Issuer through each such vesting date. Read SEC document |
| October 06, 2025 Filed Oct 8, 2025 21:35 UTC |
Chuang EmilDirector
|
GrantRestricted Stock Units · Derivative | 510,700 | $0.00 | $0.00 |
DisclosureSEC source: 0001493152-25-017473 · ownership.xml · derivative · entry 1 Chuang Emil · CIK 0001921045 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 510,700 Underlying: Common Stock · 510,700 shares Expires not disclosed F1 · derivative.exercise_price: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Issuer's common stock, provided that, until such time as the Issuer has sufficient shares of Issuer common stock reserved under its 2021 Equity Incentive Plan to issue upon settlement of all outstanding grants thereunder, the RSUs may be settled upon vesting in cash. F2 · derivative.exercise_date: The RSUs are subject to a service-based vesting requirement and shall vest in three equal annual installments, which shall be satisfied on the earlier of (i) the date of the next annual meeting of stockholders or (ii) the anniversary of October 6, 2025, subject to the Reporting Person's continuous service with the Issuer through such date. F2 · derivative.expiration_date: The RSUs are subject to a service-based vesting requirement and shall vest in three equal annual installments, which shall be satisfied on the earlier of (i) the date of the next annual meeting of stockholders or (ii) the anniversary of October 6, 2025, subject to the Reporting Person's continuous service with the Issuer through such date. Read SEC document |
| October 06, 2025 Filed Nov 7, 2025 01:21 UTC Amendment |
Williams Donald AllenDirector
|
GrantRestricted Stock Units · Derivative | 182,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001493152-25-021134 · ownership.xml · derivative · entry 1 Williams Donald Allen · CIK 0001620013 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 182,000 Underlying: Common Stock · 182,000 shares Expires not disclosed F1 · derivative.exercise_price: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Issuer's common stock, provided that, until such time as the Issuer has sufficient shares of Issuer common stock reserved under its 2021 Equity Incentive Plan (the "Plan") to issue upon settlement of all outstanding grants thereunder, the RSUs may be settled upon vesting in cash. F2 · shares: This amended Form 4 is being filed to correct the previously reported grant amount of 1,538,700 RSUs to the Reporting Person. The Issuer has rescinded the grant of 1,356,700 RSUs of the previously reported grant of 1,538,700 RSUs. F3 · derivative.exercise_date: The RSUs are subject to a service-based vesting requirement and shall vest in three equal annual installments, with the first installment vesting on the earlier of (i) the date of the 2026 annual meeting of stockholders or (ii) the anniversary of October 6, 2025, subject to the Reporting Person's continuous service with the Issuer through such date. F3 · derivative.expiration_date: The RSUs are subject to a service-based vesting requirement and shall vest in three equal annual installments, with the first installment vesting on the earlier of (i) the date of the 2026 annual meeting of stockholders or (ii) the anniversary of October 6, 2025, subject to the Reporting Person's continuous service with the Issuer through such date. Read SEC document |
| October 06, 2025 Filed Nov 7, 2025 01:18 UTC Amendment |
Chuang EmilDirector
|
GrantRestricted Stock Units · Derivative | 60,600 | $0.00 | $0.00 |
DisclosureSEC source: 0001493152-25-021132 · ownership.xml · derivative · entry 1 Chuang Emil · CIK 0001921045 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 60,600 Underlying: Common Stock · 60,600 shares Expires not disclosed F1 · derivative.exercise_price: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Issuer's common stock, provided that, until such time as the Issuer has sufficient shares of Issuer common stock reserved under its 2021 Equity Incentive Plan (the "Plan") to issue upon settlement of all outstanding grants thereunder, the RSUs may be settled upon vesting in cash. F2 · shares: This amended Form 4 is being filed to correct the previously reported grant amount of 510,700 RSUs to the Reporting Person. The Issuer has rescinded the grant of 450,100 RSUs of the previously reported grant of 510,700 RSUs. F3 · derivative.exercise_date: The RSUs are subject to a service-based vesting requirement and shall vest in three equal annual installments, with the first installment vesting on the earlier of (i) the date of the 2026 annual meeting of stockholders or (ii) the anniversary of October 6, 2025, subject to the Reporting Person's continuous service with the Issuer through such date. F3 · derivative.expiration_date: The RSUs are subject to a service-based vesting requirement and shall vest in three equal annual installments, with the first installment vesting on the earlier of (i) the date of the 2026 annual meeting of stockholders or (ii) the anniversary of October 6, 2025, subject to the Reporting Person's continuous service with the Issuer through such date. Read SEC document |
| October 06, 2025 Filed Nov 7, 2025 01:20 UTC Amendment |
Wei BinxianDirector
|
GrantRestricted Stock Units · Derivative | 60,600 | $0.00 | $0.00 |
DisclosureSEC source: 0001493152-25-021133 · ownership.xml · derivative · entry 1 Wei Binxian · CIK 0001773586 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 60,600 Underlying: Common Stock · 60,600 shares Expires not disclosed F1 · derivative.exercise_price: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Issuer's common stock, provided that, until such time as the Issuer has sufficient shares of Issuer common stock reserved under its 2021 Equity Incentive Plan (the "Plan") to issue upon settlement of all outstanding grants thereunder, the RSUs may be settled upon vesting in cash. F2 · shares: This amended Form 4 is being filed to correct the previously reported grant amount of 510,700 RSUs to the Reporting Person. The Issuer has rescinded the grant of 450,100 RSUs of the previously reported grant of 510,700 RSUs. F3 · derivative.exercise_date: The RSUs are subject to a service-based vesting requirement and shall vest in three equal annual installments, with the first installment vesting on the earlier of (i) the date of the 2026 annual meeting of stockholders or (ii) the anniversary of October 6, 2025, subject to the Reporting Person's continuous service with the Issuer through such date. F3 · derivative.expiration_date: The RSUs are subject to a service-based vesting requirement and shall vest in three equal annual installments, with the first installment vesting on the earlier of (i) the date of the 2026 annual meeting of stockholders or (ii) the anniversary of October 6, 2025, subject to the Reporting Person's continuous service with the Issuer through such date. Read SEC document |
| September 04, 2025 Filed Sep 5, 2025 13:00 UTC |
Finley John DavidDirector · CEO, CFO
|
GrantPhantom Units · Derivative | 323,400 | $0.00 | $0.00 |
DisclosureSEC source: 0001493152-25-012690 · ownership.xml · derivative · entry 1 Finley John David · CIK 0001851034 · Director · CEO, CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 323,400 Underlying: Common Stock · 323,400 shares Expires not disclosed F1 · derivative.exercise_price: Each Phantom Unit is the economic equivalent of one share of the Issuer's common stock. F2 · derivative.exercise_date: The Phantom Units vest in 12 equal quarterly installments beginning on November 5, 2025, subject to the Reporting Person's continuous service through each applicable vesting date. F3 · derivative.exercise_date: Vested Phantom Units shall be settled solely in cash based on the fair market value of an equal number of shares of the Issuer's common stock on the earliest to occur of any of the following events: (a) termination of the Reporting Person's continuous service by the Issuer without Cause; (b) a Liquidity Change in Control of the Issuer; or (c) 7th anniversary of the grant date, in each case as such capitalized terms are defined in the Issuer's Phantom Unit Plan. F2 · derivative.expiration_date: The Phantom Units vest in 12 equal quarterly installments beginning on November 5, 2025, subject to the Reporting Person's continuous service through each applicable vesting date. F3 · derivative.expiration_date: Vested Phantom Units shall be settled solely in cash based on the fair market value of an equal number of shares of the Issuer's common stock on the earliest to occur of any of the following events: (a) termination of the Reporting Person's continuous service by the Issuer without Cause; (b) a Liquidity Change in Control of the Issuer; or (c) 7th anniversary of the grant date, in each case as such capitalized terms are defined in the Issuer's Phantom Unit Plan. Read SEC document |
| September 04, 2025 Filed Sep 5, 2025 13:00 UTC |
Williams Donald AllenDirector
|
GrantPhantom Units · Derivative | 64,400 | $0.00 | $0.00 |
DisclosureSEC source: 0001493152-25-012693 · ownership.xml · derivative · entry 1 Williams Donald Allen · CIK 0001620013 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 64,400 Underlying: Common Stock · 64,400 shares Expires not disclosed F1 · derivative.exercise_price: Each Phantom Unit is the economic equivalent of one share of the Issuer's common stock. F2 · derivative.exercise_date: The Phantom Units vest in three equal annual installments beginning on August 5, 2026, subject to the Reporting Person's continuous service through each applicable vesting date F3 · derivative.exercise_date: Vested Phantom Units shall be settled solely in cash based on the fair market value of an equal number of shares of the Issuer's common stock on the earliest to occur of any of the following events: (a) termination of the Reporting Person's continuous service with the Issuer; (b) a Liquidity Change in Control (as defined in the Phantom Unit Plan) of the Issuer; or (c) 7th anniversary of the grant date. F2 · derivative.expiration_date: The Phantom Units vest in three equal annual installments beginning on August 5, 2026, subject to the Reporting Person's continuous service through each applicable vesting date F3 · derivative.expiration_date: Vested Phantom Units shall be settled solely in cash based on the fair market value of an equal number of shares of the Issuer's common stock on the earliest to occur of any of the following events: (a) termination of the Reporting Person's continuous service with the Issuer; (b) a Liquidity Change in Control (as defined in the Phantom Unit Plan) of the Issuer; or (c) 7th anniversary of the grant date. Read SEC document |
| September 04, 2025 Filed Sep 5, 2025 13:00 UTC |
Wei BinxianDirector
|
GrantPhantom Units · Derivative | 18,800 | $0.00 | $0.00 |
DisclosureSEC source: 0001493152-25-012692 · ownership.xml · derivative · entry 1 Wei Binxian · CIK 0001773586 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 18,800 Underlying: Common Stock · 18,800 shares Expires not disclosed F1 · derivative.exercise_price: Each Phantom Unit is the economic equivalent of one share of the Issuer's common stock. F2 · derivative.exercise_date: The Phantom Units vest in three equal annual installments beginning on August 5, 2026, subject to the Reporting Person's continuous service through each applicable vesting date. F3 · derivative.exercise_date: Vested Phantom Units shall be settled solely in cash based on the fair market value of an equal number of shares of the Issuer's common stock on the earliest to occur of any of the following events: (a) termination of the Reporting Person's continuous service with the Issuer; (b) a Liquidity Change in Control (as defined in the Phantom Unit Plan) of the Issuer; or (c) 7th anniversary of the grant date. F2 · derivative.expiration_date: The Phantom Units vest in three equal annual installments beginning on August 5, 2026, subject to the Reporting Person's continuous service through each applicable vesting date. F3 · derivative.expiration_date: Vested Phantom Units shall be settled solely in cash based on the fair market value of an equal number of shares of the Issuer's common stock on the earliest to occur of any of the following events: (a) termination of the Reporting Person's continuous service with the Issuer; (b) a Liquidity Change in Control (as defined in the Phantom Unit Plan) of the Issuer; or (c) 7th anniversary of the grant date. Read SEC document |
| September 04, 2025 Filed Sep 5, 2025 13:00 UTC |
Jones Mitchell LawrenceChief Medical Officer
|
GrantPhantom Units · Derivative | 289,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001493152-25-012691 · ownership.xml · derivative · entry 1 Jones Mitchell Lawrence · CIK 0001993292 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 289,000 Underlying: Common Stock · 289,000 shares Expires not disclosed F1 · derivative.exercise_price: Each Phantom Unit is the economic equivalent of one share of the Issuer's common stock. F2 · derivative.exercise_date: The Phantom Units vest in 12 equal quarterly installments beginning on November 5, 2025, subject to the Reporting Person's continuous service through each applicable vesting date. F3 · derivative.exercise_date: Vested Phantom Units shall be settled solely in cash based on the fair market value of an equal number of shares of the Issuer's common stock on the earliest to occur of any of the following events: (a) termination of the Reporting Person's continuous service by the Issuer without Cause; (b) a Liquidity Change in Control of the Issuer; or (c) 7th anniversary of the grant date, in each case as such capitalized terms are defined in the Issuer's Phantom Unit Plan. F2 · derivative.expiration_date: The Phantom Units vest in 12 equal quarterly installments beginning on November 5, 2025, subject to the Reporting Person's continuous service through each applicable vesting date. F3 · derivative.expiration_date: Vested Phantom Units shall be settled solely in cash based on the fair market value of an equal number of shares of the Issuer's common stock on the earliest to occur of any of the following events: (a) termination of the Reporting Person's continuous service by the Issuer without Cause; (b) a Liquidity Change in Control of the Issuer; or (c) 7th anniversary of the grant date, in each case as such capitalized terms are defined in the Issuer's Phantom Unit Plan. Read SEC document |
| September 04, 2025 Filed Sep 5, 2025 13:00 UTC |
Chuang EmilDirector
|
GrantPhantom Units · Derivative | 18,800 | $0.00 | $0.00 |
DisclosureSEC source: 0001493152-25-012689 · ownership.xml · derivative · entry 1 Chuang Emil · CIK 0001921045 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 18,800 Underlying: Common Stock · 18,800 shares Expires not disclosed F1 · derivative.exercise_price: Each Phantom Unit is the economic equivalent of one share of the Issuer's common stock. F2 · derivative.exercise_date: The Phantom Units vest in three equal annual installments beginning on August 5, 2026, subject to the Reporting Person's continuous service through each applicable vesting date. F3 · derivative.exercise_date: Vested Phantom Units shall be settled solely in cash based on the fair market value of an equal number of shares of the Issuer's common stock on the earliest to occur of any of the following events: (a) termination of the Reporting Person's continuous service with the Issuer; (b) a Liquidity Change in Control (as defined in the Phantom Unit Plan) of the Issuer; or (c) 7th anniversary of the grant date. F2 · derivative.expiration_date: The Phantom Units vest in three equal annual installments beginning on August 5, 2026, subject to the Reporting Person's continuous service through each applicable vesting date. F3 · derivative.expiration_date: Vested Phantom Units shall be settled solely in cash based on the fair market value of an equal number of shares of the Issuer's common stock on the earliest to occur of any of the following events: (a) termination of the Reporting Person's continuous service with the Issuer; (b) a Liquidity Change in Control (as defined in the Phantom Unit Plan) of the Issuer; or (c) 7th anniversary of the grant date. Read SEC document |
| July 18, 2025 Filed Jul 22, 2025 20:22 UTC |
Chuang EmilDirector
|
GrantStock Option (Right to Buy) · Derivative | 8,000 | $0.00 Strike: $0.75 | $0.00 |
DisclosureSEC source: 0001641172-25-020579 · ownership.xml · derivative · entry 1 Chuang Emil · CIK 0001921045 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,000 Underlying: Common Stock · 8,000 shares Expires 2035-07-18 F1 · derivative.exercise_date: The option shall vest with respect to 8.33% of the underlying shares subject to the option in equal quarterly installments such that the option shall be fully vested on the three-year anniversary of July 18, 2025, subject to the reporting person's continued service as a member of the Issuer's Board of Directors through each applicable vesting date. Read SEC document |
| February 11, 2025 Filed Feb 13, 2025 22:56 UTC |
Finley John DavidDirector · CEO, CFO
|
GrantRestricted Stock Units · Derivative | 40,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001493152-25-006498 · ownership.xml · derivative · entry 2 Finley John David · CIK 0001851034 · Director · CEO, CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 40,000 Underlying: Common Stock · 40,000 shares Expires not disclosed F2 · derivative.exercise_price: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Issuer's common stock. F3 · derivative.exercise_date: The RSUs shall vest in three equal annual installments beginning on February 11, 2026, subject to the Reporting Person's continuous service through each such vesting date. F3 · derivative.expiration_date: The RSUs shall vest in three equal annual installments beginning on February 11, 2026, subject to the Reporting Person's continuous service through each such vesting date. Read SEC document |
| February 11, 2025 Filed Feb 13, 2025 22:56 UTC |
Finley John DavidDirector · CEO, CFO
|
GrantStock Option (Right to Buy) · Derivative | 47,000 | $0.00 Strike: $1.13 | $0.00 |
DisclosureSEC source: 0001493152-25-006498 · ownership.xml · derivative · entry 1 Finley John David · CIK 0001851034 · Director · CEO, CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 47,000 Underlying: Common Stock · 47,000 shares Expires 2035-02-11 F1 · derivative.exercise_date: The shares subject to this option shall vest and become exercisable in twelve equal quarterly installments over a three-year period beginning on May 11, 2025, subject to the Reporting Person's continuous service through each such vesting date. Read SEC document |
| February 11, 2025 Filed Feb 13, 2025 22:58 UTC |
Jones Mitchell LawrenceChief Medical Officer
|
GrantRestricted Stock Units · Derivative | 24,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001493152-25-006500 · ownership.xml · derivative · entry 2 Jones Mitchell Lawrence · CIK 0001993292 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 24,000 Underlying: Common Stock · 24,000 shares Expires not disclosed F2 · derivative.exercise_price: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Issuer's common stock. F3 · derivative.exercise_date: The RSUs shall vest in three equal annual installments beginning on February 11, 2026, subject to the Reporting Person's continuous service to the Issuer through each such vesting date. F3 · derivative.expiration_date: The RSUs shall vest in three equal annual installments beginning on February 11, 2026, subject to the Reporting Person's continuous service to the Issuer through each such vesting date. Read SEC document |
| February 11, 2025 Filed Feb 13, 2025 22:58 UTC |
Jones Mitchell LawrenceChief Medical Officer
|
GrantStock Option (Right to Buy) · Derivative | 29,000 | $0.00 Strike: $1.13 | $0.00 |
DisclosureSEC source: 0001493152-25-006500 · ownership.xml · derivative · entry 1 Jones Mitchell Lawrence · CIK 0001993292 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 29,000 Underlying: Common Stock · 29,000 shares Expires 2035-02-11 F1 · derivative.exercise_date: The shares subject to this option shall vest and become exercisable in twelve equal quarterly installments over a three-year period with vesting commencing on May 11, 2025, subject to the Reporting Person's continuous service to the Issuer through each such vesting date. Read SEC document |
| November 21, 2024 Filed Nov 22, 2024 21:00 UTC |
Williams Donald AllenDirector
|
Exercise / conversionComon Stock, par value $0.01 | 388 | $0.00 | $0.00 |
DisclosureSEC source: 0001493152-24-047363 · ownership.xml · nonDerivative · entry 1 Williams Donald Allen · CIK 0001620013 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 728 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Represents the issuance of common stock upon the full vesting and settlement of outstanding restricted stock units granted on November 21, 2023. F1 · price: Represents the issuance of common stock upon the full vesting and settlement of outstanding restricted stock units granted on November 21, 2023. Read SEC document |
| November 21, 2024 Filed Nov 22, 2024 21:00 UTC |
Wei BinxianDirector
|
Exercise / conversionComon Stock, par value $0.01 | 388 | $0.00 | $0.00 |
DisclosureSEC source: 0001493152-24-047364 · ownership.xml · nonDerivative · entry 1 Wei Binxian · CIK 0001773586 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 855 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Represents the issuance of common stock upon the full vesting and settlement of outstanding restricted stock units granted on November 21, 2023. F1 · price: Represents the issuance of common stock upon the full vesting and settlement of outstanding restricted stock units granted on November 21, 2023. Read SEC document |
| July 11, 2024 Filed Jul 16, 2024 00:19 UTC |
Wei BinxianDirector
|
GrantCommon Stock Options · Derivative | 2,100 | $0.00 Strike: $4.49 | $0.00 |
DisclosureSEC source: 0001493152-24-027911 · ownership.xml · derivative · entry 1 Wei Binxian · CIK 0001773586 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,100 Underlying: Common Stock · 2,100 shares Expires 2034-07-11 F1 · security: Represents partial compensation for services as a director pursuant to Issuer's non-employee director compensation policy, consisting of 2,100 common stock purchase options. The grants were issued from Issuer's 2021 Equity Incentive Plan. F2 · security: The grants vest fully on the one (1) year anniversary of the grant date. F3 · security: Each option represents the right to purchase one share of common stock at the exercise price. F2 · derivative.exercise_date: The grants vest fully on the one (1) year anniversary of the grant date. Read SEC document |
| July 11, 2024 Filed Jul 16, 2024 00:13 UTC |
Fischbein Margery B.Director
|
GrantCommon Stock Options · Derivative | 2,100 | $0.00 Strike: $4.49 | $0.00 |
DisclosureSEC source: 0001493152-24-027909 · ownership.xml · derivative · entry 1 Fischbein Margery B. · CIK 0001766438 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,100 Underlying: Common Stock · 2,100 shares Expires 2034-07-11 F1 · security: Represents partial compensation for services as a director pursuant to Issuer's non-employee director compensation policy, consisting of 2,100 common stock purchase options. The grants were issued from Issuer's 2021 Equity Incentive Plan. F2 · security: The grants vest fully on the one (1) year anniversary of the grant date. F3 · security: Each option represents the right to purchase one share of common stock at the exercise price. F2 · derivative.exercise_date: The grants vest fully on the one (1) year anniversary of the grant date. Read SEC document |
| July 11, 2024 Filed Jul 16, 2024 00:10 UTC |
Williams Donald AllenDirector
|
GrantCommon Stock Options · Derivative | 2,100 | $0.00 Strike: $4.49 | $0.00 |
DisclosureSEC source: 0001493152-24-027907 · ownership.xml · derivative · entry 1 Williams Donald Allen · CIK 0001620013 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,100 Underlying: Common Stock · 2,100 shares Expires 2034-07-11 F1 · security: Represents partial compensation for services as a director pursuant to Issuer's non-employee director compensation policy, consisting of 2,100 common stock purchase options. The grants were issued from Issuer's 2021 Equity Incentive Plan. F2 · security: The grants vest fully on the one (1) year anniversary of the grant date. F3 · security: Each option represents the right to purchase one share of common stock at the exercise price. F2 · derivative.exercise_date: The grants vest fully on the one (1) year anniversary of the grant date. Read SEC document |
| June 11, 2024 Filed Jun 13, 2024 01:41 UTC |
Wei BinxianDirector
|
Exercise / conversionComon Stock, par value $0.01 | 465 | $0.00 | $0.00 |
DisclosureSEC source: 0001493152-24-023614 · ownership.xml · nonDerivative · entry 1 Wei Binxian · CIK 0001773586 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 467 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: Represents the issuance of common stock upon the vesting and settlement of outstanding restricted stock units for the restricted stock units granted on June 11, 2023. F1 · shares: Represents the issuance of common stock upon the vesting and settlement of outstanding restricted stock units for the restricted stock units granted on June 11, 2023. F1 · price: Represents the issuance of common stock upon the vesting and settlement of outstanding restricted stock units for the restricted stock units granted on June 11, 2023. Read SEC document |
| June 11, 2024 Filed Jun 13, 2024 01:40 UTC |
Williams Donald AllenDirector
|
Exercise / conversionComon Stock, par value $0.01 | 340 | $0.00 | $0.00 |
DisclosureSEC source: 0001493152-24-023612 · ownership.xml · nonDerivative · entry 1 Williams Donald Allen · CIK 0001620013 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 340 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: Represents the issuance of common stock upon the vesting and settlement of outstanding restricted stock units for the restricted stock units granted on June 11, 2023. F1 · shares: Represents the issuance of common stock upon the vesting and settlement of outstanding restricted stock units for the restricted stock units granted on June 11, 2023. F1 · price: Represents the issuance of common stock upon the vesting and settlement of outstanding restricted stock units for the restricted stock units granted on June 11, 2023. Read SEC document |
| May 28, 2024 Filed May 29, 2024 19:47 UTC |
Williams Donald AllenDirector
|
PurchaseComon Stock, par value $0.01 | 1,000 | $4.86 | $4,863.00 |
DisclosureSEC source: 0001493152-24-021777 · ownership.xml · nonDerivative · entry 1 Williams Donald Allen · CIK 0001620013 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,000 F1 · shares: Reporting Person purchased 1,000 shares of Common Stock of Issuer at a price per share of $4.863 on May 28, 2024. Read SEC document |
| May 28, 2024 Filed May 30, 2024 23:44 UTC |
Finley John DavidDirector · CEO, CFO, Director
|
Exercise / conversionRestricted Stock Units · Derivative | 2,111 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001493152-24-022037 · ownership.xml · derivative · entry 10 Finley John David · CIK 0001851034 · Director · CEO, CFO, Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,111 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F11 · security: This restricted stock unit was granted on November 21, 2023, and all remaining 2,111 restricted stock units subject to the award were accelerated and vested on May 28, 2024 by the Compensation Committee of the Issuer. F11 · derivative.exercise_price: This restricted stock unit was granted on November 21, 2023, and all remaining 2,111 restricted stock units subject to the award were accelerated and vested on May 28, 2024 by the Compensation Committee of the Issuer. F11 · price: This restricted stock unit was granted on November 21, 2023, and all remaining 2,111 restricted stock units subject to the award were accelerated and vested on May 28, 2024 by the Compensation Committee of the Issuer. F8 · derivative.exercise_date: Each restricted stock unit represents the right to receive, at settlement, one share of common stock. F8 · derivative.expiration_date: Each restricted stock unit represents the right to receive, at settlement, one share of common stock. Read SEC document |
| May 28, 2024 Filed May 30, 2024 23:44 UTC |
Finley John DavidDirector · CEO, CFO, Director
|
Exercise / conversionRestricted Stock Units · Derivative | 3,335 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001493152-24-022037 · ownership.xml · derivative · entry 9 Finley John David · CIK 0001851034 · Director · CEO, CFO, Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 3,335 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F10 · security: This restricted stock unit was granted on June 11, 2023, and all remaining 3,335 restricted stock units subject to the award were accelerated and vested on May 28, 2024 by the Compensation Committee of the Issuer. F10 · derivative.exercise_price: This restricted stock unit was granted on June 11, 2023, and all remaining 3,335 restricted stock units subject to the award were accelerated and vested on May 28, 2024 by the Compensation Committee of the Issuer. F10 · price: This restricted stock unit was granted on June 11, 2023, and all remaining 3,335 restricted stock units subject to the award were accelerated and vested on May 28, 2024 by the Compensation Committee of the Issuer. F8 · derivative.exercise_date: Each restricted stock unit represents the right to receive, at settlement, one share of common stock. F8 · derivative.expiration_date: Each restricted stock unit represents the right to receive, at settlement, one share of common stock. Read SEC document |
| May 28, 2024 Filed May 30, 2024 23:44 UTC |
Finley John DavidDirector · CEO, CFO, Director
|
Exercise / conversionRestricted Stock Units · Derivative | 1,622 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001493152-24-022037 · ownership.xml · derivative · entry 8 Finley John David · CIK 0001851034 · Director · CEO, CFO, Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,622 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F9 · security: This restricted stock unit was granted on June 8, 2023, and all remaining 1,622 restricted stock units subject to the award were accelerated and vested on May 28, 2024 by the Compensation Committee of the Issuer. F9 · derivative.exercise_price: This restricted stock unit was granted on June 8, 2023, and all remaining 1,622 restricted stock units subject to the award were accelerated and vested on May 28, 2024 by the Compensation Committee of the Issuer. F9 · price: This restricted stock unit was granted on June 8, 2023, and all remaining 1,622 restricted stock units subject to the award were accelerated and vested on May 28, 2024 by the Compensation Committee of the Issuer. F8 · derivative.exercise_date: Each restricted stock unit represents the right to receive, at settlement, one share of common stock. F8 · derivative.expiration_date: Each restricted stock unit represents the right to receive, at settlement, one share of common stock. Read SEC document |
| May 28, 2024 Filed May 30, 2024 23:44 UTC |
Finley John DavidDirector · CEO, CFO, Director
|
Tax withholdingCommon Stock, par value $0.01 | 607 | $4.76 | $2,889.32 |
DisclosureSEC source: 0001493152-24-022037 · ownership.xml · nonDerivative · entry 6 Finley John David · CIK 0001851034 · Director · CEO, CFO, Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 13,472 F6 · security: Represents shares withheld to cover tax withholding obligations in connection with the vesting and settlement of the restricted stock units referenced in footnote 5. F6 · shares: Represents shares withheld to cover tax withholding obligations in connection with the vesting and settlement of the restricted stock units referenced in footnote 5. Read SEC document |
| May 28, 2024 Filed May 30, 2024 23:44 UTC |
Finley John DavidDirector · CEO, CFO, Director
|
Exercise / conversionCommon Stock, par value $0.01 | 2,111 | $0.00 | $0.00 |
DisclosureSEC source: 0001493152-24-022037 · ownership.xml · nonDerivative · entry 5 Finley John David · CIK 0001851034 · Director · CEO, CFO, Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 14,079 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · security: Represents the issuance of common stock upon the vesting and settlement of outstanding restricted stock units for the restricted stock units granted on November 21, 2023. F5 · shares: Represents the issuance of common stock upon the vesting and settlement of outstanding restricted stock units for the restricted stock units granted on November 21, 2023. F5 · price: Represents the issuance of common stock upon the vesting and settlement of outstanding restricted stock units for the restricted stock units granted on November 21, 2023. Read SEC document |
| May 28, 2024 Filed May 30, 2024 23:44 UTC |
Finley John DavidDirector · CEO, CFO, Director
|
Tax withholdingCommon Stock, par value $0.01 | 959 | $4.76 | $4,564.84 |
DisclosureSEC source: 0001493152-24-022037 · ownership.xml · nonDerivative · entry 4 Finley John David · CIK 0001851034 · Director · CEO, CFO, Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 11,968 F4 · security: Represents shares withheld to cover tax withholding obligations in connection with the vesting and settlement of the restricted stock units referenced in footnote 3. F4 · shares: Represents shares withheld to cover tax withholding obligations in connection with the vesting and settlement of the restricted stock units referenced in footnote 3. Read SEC document |
| May 28, 2024 Filed May 30, 2024 23:44 UTC |
Finley John DavidDirector · CEO, CFO, Director
|
Exercise / conversionCommon Stock, par value $0.01 | 3,335 | $0.00 | $0.00 |
DisclosureSEC source: 0001493152-24-022037 · ownership.xml · nonDerivative · entry 3 Finley John David · CIK 0001851034 · Director · CEO, CFO, Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,927 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · security: Represents the issuance of common stock upon the vesting and settlement of outstanding restricted stock units for the restricted stock units granted on June 11, 2023. F3 · shares: Represents the issuance of common stock upon the vesting and settlement of outstanding restricted stock units for the restricted stock units granted on June 11, 2023. F3 · price: Represents the issuance of common stock upon the vesting and settlement of outstanding restricted stock units for the restricted stock units granted on June 11, 2023. Read SEC document |
| May 28, 2024 Filed May 30, 2024 23:44 UTC |
Finley John DavidDirector · CEO, CFO, Director
|
Tax withholdingCommon Stock, par value $0.01 | 467 | $4.76 | $2,222.92 |
DisclosureSEC source: 0001493152-24-022037 · ownership.xml · nonDerivative · entry 2 Finley John David · CIK 0001851034 · Director · CEO, CFO, Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,592 F2 · security: Represents shares withheld to cover tax withholding obligations in connection with the vesting and settlement of the restricted stock units referenced in footnote 1. F2 · shares: Represents shares withheld to cover tax withholding obligations in connection with the vesting and settlement of the restricted stock units referenced in footnote 1. Read SEC document |
| May 28, 2024 Filed May 30, 2024 23:44 UTC |
Finley John DavidDirector · CEO, CFO, Director
|
Exercise / conversionCommon Stock, par value $0.01 | 1,622 | $0.00 | $0.00 |
DisclosureSEC source: 0001493152-24-022037 · ownership.xml · nonDerivative · entry 1 Finley John David · CIK 0001851034 · Director · CEO, CFO, Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,059 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: Represents the issuance of common stock upon the vesting and settlement of outstanding restricted stock units for the restricted stock units granted on June 8, 2023. F1 · shares: Represents the issuance of common stock upon the vesting and settlement of outstanding restricted stock units for the restricted stock units granted on June 8, 2023. F1 · price: Represents the issuance of common stock upon the vesting and settlement of outstanding restricted stock units for the restricted stock units granted on June 8, 2023. Read SEC document |
| May 28, 2024 Filed May 30, 2024 23:44 UTC |
Jones Mitchell LawrenceChief Medical Officer
|
Exercise / conversionRestricted Stock Units · Derivative | 1,555 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001493152-24-022038 · ownership.xml · derivative · entry 6 Jones Mitchell Lawrence · CIK 0001993292 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,555 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F7 · security: This restricted stock unit was granted on November 21 2024, and all remaining 1,555 restricted stock units subject to the award were accelerated and vested on May 28, 2024 by the Compensation Committee of the Issuer. F7 · derivative.exercise_price: This restricted stock unit was granted on November 21 2024, and all remaining 1,555 restricted stock units subject to the award were accelerated and vested on May 28, 2024 by the Compensation Committee of the Issuer. F7 · price: This restricted stock unit was granted on November 21 2024, and all remaining 1,555 restricted stock units subject to the award were accelerated and vested on May 28, 2024 by the Compensation Committee of the Issuer. F5 · derivative.exercise_date: Each restricted stock unit represents the right to receive, at settlement, one share of common stock. F5 · derivative.expiration_date: Each restricted stock unit represents the right to receive, at settlement, one share of common stock. Read SEC document |
| May 28, 2024 Filed May 30, 2024 23:44 UTC |
Jones Mitchell LawrenceChief Medical Officer
|
Exercise / conversionRestricted Stock Units · Derivative | 2,735 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001493152-24-022038 · ownership.xml · derivative · entry 5 Jones Mitchell Lawrence · CIK 0001993292 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,735 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · security: This restricted stock unit was granted on September 5, 2023, and all remaining 2,735 restricted stock units subject to the award were accelerated and vested on May 28, 2024 by the Compensation Committee of the Issuer. F6 · derivative.exercise_price: This restricted stock unit was granted on September 5, 2023, and all remaining 2,735 restricted stock units subject to the award were accelerated and vested on May 28, 2024 by the Compensation Committee of the Issuer. F6 · price: This restricted stock unit was granted on September 5, 2023, and all remaining 2,735 restricted stock units subject to the award were accelerated and vested on May 28, 2024 by the Compensation Committee of the Issuer. F5 · derivative.exercise_date: Each restricted stock unit represents the right to receive, at settlement, one share of common stock. F5 · derivative.expiration_date: Each restricted stock unit represents the right to receive, at settlement, one share of common stock. Read SEC document |
| May 28, 2024 Filed May 30, 2024 23:44 UTC |
Jones Mitchell LawrenceChief Medical Officer
|
Tax withholdingCommon Stock, par value $0.01 | 461 | $4.76 | $2,194.36 |
DisclosureSEC source: 0001493152-24-022038 · ownership.xml · nonDerivative · entry 4 Jones Mitchell Lawrence · CIK 0001993292 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,852 F4 · security: Represents shares withheld to cover tax withholding obligations in connection with the vesting and settlement of the restricted stock units referenced in footnote 3. F4 · shares: Represents shares withheld to cover tax withholding obligations in connection with the vesting and settlement of the restricted stock units referenced in footnote 3. Read SEC document |
| May 28, 2024 Filed May 30, 2024 23:44 UTC |
Jones Mitchell LawrenceChief Medical Officer
|
Exercise / conversionCommon Stock, par value $0.01 | 1,555 | $0.00 | $0.00 |
DisclosureSEC source: 0001493152-24-022038 · ownership.xml · nonDerivative · entry 3 Jones Mitchell Lawrence · CIK 0001993292 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,313 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · security: Represents the issuance of common stock upon the vesting and settlement of outstanding restricted stock units for the restricted stock units granted on November 21, 2023. F3 · shares: Represents the issuance of common stock upon the vesting and settlement of outstanding restricted stock units for the restricted stock units granted on November 21, 2023. F3 · price: Represents the issuance of common stock upon the vesting and settlement of outstanding restricted stock units for the restricted stock units granted on November 21, 2023. Read SEC document |
| May 28, 2024 Filed May 30, 2024 23:44 UTC |
Jones Mitchell LawrenceChief Medical Officer
|
Tax withholdingCommon Stock, par value $0.01 | 810 | $4.76 | $3,855.60 |
DisclosureSEC source: 0001493152-24-022038 · ownership.xml · nonDerivative · entry 2 Jones Mitchell Lawrence · CIK 0001993292 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,758 F2 · security: Represents shares withheld to cover tax withholding obligations in connection with the vesting and settlement of the restricted stock units referenced in footnote 1. F2 · shares: Represents shares withheld to cover tax withholding obligations in connection with the vesting and settlement of the restricted stock units referenced in footnote 1. Read SEC document |
| May 28, 2024 Filed May 30, 2024 23:44 UTC |
Jones Mitchell LawrenceChief Medical Officer
|
Exercise / conversionCommon Stock, par value $0.01 | 2,735 | $0.00 | $0.00 |
DisclosureSEC source: 0001493152-24-022038 · ownership.xml · nonDerivative · entry 1 Jones Mitchell Lawrence · CIK 0001993292 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,568 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: Represents the issuance of common stock upon the vesting and settlement of outstanding restricted stock units for the restricted stock units granted on September 5, 2023. F1 · shares: Represents the issuance of common stock upon the vesting and settlement of outstanding restricted stock units for the restricted stock units granted on September 5, 2023. F1 · price: Represents the issuance of common stock upon the vesting and settlement of outstanding restricted stock units for the restricted stock units granted on September 5, 2023. Read SEC document |
| May 24, 2024 Filed May 28, 2024 10:02 UTC |
Finley John DavidDirector · CEO, CFO, Director
|
PurchaseCommon Stock, par value $0.01 | 1,000 | $4.81 | $4,810.00 |
DisclosureSEC source: 0001493152-24-021431 · ownership.xml · nonDerivative · entry 1 Finley John David · CIK 0001851034 · Director · CEO, CFO, Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,437 F1 · security: Reporting Person purchased 1,000 shares of Common Stock of Issuer at a price per share of $4.81 on May 24, 2024. F1 · shares: Reporting Person purchased 1,000 shares of Common Stock of Issuer at a price per share of $4.81 on May 24, 2024. F1 · price: Reporting Person purchased 1,000 shares of Common Stock of Issuer at a price per share of $4.81 on May 24, 2024. Read SEC document |
| May 20, 2024 Filed May 22, 2024 20:52 UTC |
Finley John DavidDirector · CEO, CFO, Director
|
GrantCommon Stock, par value $0.01 | 666 | $4.97 | $3,311.69 |
DisclosureSEC source: 0001493152-24-021045 · ownership.xml · nonDerivative · entry 1 Finley John David · CIK 0001851034 · Director · CEO, CFO, Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,437 F1 · security: Shares were purchased pursuant to the Palisade Bio, Inc. 2021 Employee Stock Purchase Plan, as amended ("ESPP") for the ESPP purchase period from November 21, 2023 through May 20, 2024. In accordance with the ESPP, the shares were purchased in a transaction exempt under Rule 16b-3(c) at a price equal to 85% of the closing price of the issuer's common stock on May 20, 2024. F1 · shares: Shares were purchased pursuant to the Palisade Bio, Inc. 2021 Employee Stock Purchase Plan, as amended ("ESPP") for the ESPP purchase period from November 21, 2023 through May 20, 2024. In accordance with the ESPP, the shares were purchased in a transaction exempt under Rule 16b-3(c) at a price equal to 85% of the closing price of the issuer's common stock on May 20, 2024. F1 · price: Shares were purchased pursuant to the Palisade Bio, Inc. 2021 Employee Stock Purchase Plan, as amended ("ESPP") for the ESPP purchase period from November 21, 2023 through May 20, 2024. In accordance with the ESPP, the shares were purchased in a transaction exempt under Rule 16b-3(c) at a price equal to 85% of the closing price of the issuer's common stock on May 20, 2024. Read SEC document |
| May 06, 2024 Filed May 8, 2024 22:36 UTC |
Finley John DavidDirector · CEO, CFO, Director
|
Exercise / conversionRestricted Stock Units · Derivative | 211 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001493152-24-018282 · ownership.xml · derivative · entry 7 Finley John David · CIK 0001851034 · Director · CEO, CFO, Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,111 Underlying: Common Stock · 211 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F8 · security: This restricted stock unit was granted on November 21, 2023, and 211 restricted stock units subject to the award vested on May 6, 2024, and an additional 2,111 restricted stock units will vest in equal quarterly installments over the remaining portion of the three-year period from the grant date, subject to Reporting Person continuing to be a service provider to Issuer at the time of vesting. F8 · derivative.exercise_price: This restricted stock unit was granted on November 21, 2023, and 211 restricted stock units subject to the award vested on May 6, 2024, and an additional 2,111 restricted stock units will vest in equal quarterly installments over the remaining portion of the three-year period from the grant date, subject to Reporting Person continuing to be a service provider to Issuer at the time of vesting. F8 · price: This restricted stock unit was granted on November 21, 2023, and 211 restricted stock units subject to the award vested on May 6, 2024, and an additional 2,111 restricted stock units will vest in equal quarterly installments over the remaining portion of the three-year period from the grant date, subject to Reporting Person continuing to be a service provider to Issuer at the time of vesting. F6 · derivative.exercise_date: Each restricted stock unit represents the right to receive, at settlement, one share of common stock. F6 · derivative.expiration_date: Each restricted stock unit represents the right to receive, at settlement, one share of common stock. Read SEC document |
| May 06, 2024 Filed May 8, 2024 22:36 UTC |
Finley John DavidDirector · CEO, CFO, Director
|
Exercise / conversionRestricted Stock Units · Derivative | 232 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001493152-24-018282 · ownership.xml · derivative · entry 6 Finley John David · CIK 0001851034 · Director · CEO, CFO, Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,622 Underlying: Common Stock · 232 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F7 · security: This restricted stock unit was granted on June 8, 2023, and 232 restricted stock units subject to the award vested on May 6, 2024, and an additional 1,622 restricted stock units will vest in equal quarterly installments over the remaining portion of the three-year period from the grant date, subject to Reporting Person continuing to be a service provider to Issuer at the time of vesting. F7 · derivative.exercise_price: This restricted stock unit was granted on June 8, 2023, and 232 restricted stock units subject to the award vested on May 6, 2024, and an additional 1,622 restricted stock units will vest in equal quarterly installments over the remaining portion of the three-year period from the grant date, subject to Reporting Person continuing to be a service provider to Issuer at the time of vesting. F7 · price: This restricted stock unit was granted on June 8, 2023, and 232 restricted stock units subject to the award vested on May 6, 2024, and an additional 1,622 restricted stock units will vest in equal quarterly installments over the remaining portion of the three-year period from the grant date, subject to Reporting Person continuing to be a service provider to Issuer at the time of vesting. F6 · derivative.exercise_date: Each restricted stock unit represents the right to receive, at settlement, one share of common stock. F6 · derivative.expiration_date: Each restricted stock unit represents the right to receive, at settlement, one share of common stock. Read SEC document |
| May 06, 2024 Filed May 8, 2024 22:36 UTC |
Finley John DavidDirector · CEO, CFO, Director
|
Tax withholdingCommon Stock, par value $0.01 | 61 | $8.46 | $516.06 |
DisclosureSEC source: 0001493152-24-018282 · ownership.xml · nonDerivative · entry 4 Finley John David · CIK 0001851034 · Director · CEO, CFO, Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,771 F4 · security: Represents shares withheld to cover tax withholding obligations in connection with the vesting and settlement of the restricted stock units referenced in footnote 3. F4 · shares: Represents shares withheld to cover tax withholding obligations in connection with the vesting and settlement of the restricted stock units referenced in footnote 3. Read SEC document |
| May 06, 2024 Filed May 8, 2024 22:36 UTC |
Finley John DavidDirector · CEO, CFO, Director
|
Exercise / conversionCommon Stock, par value $0.01 | 211 | $0.00 | $0.00 |
DisclosureSEC source: 0001493152-24-018282 · ownership.xml · nonDerivative · entry 3 Finley John David · CIK 0001851034 · Director · CEO, CFO, Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,832 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · security: Represents the issuance of common stock upon the vesting and settlement of outstanding restricted stock units for the restricted stock units granted on November 21, 2023. F3 · shares: Represents the issuance of common stock upon the vesting and settlement of outstanding restricted stock units for the restricted stock units granted on November 21, 2023. F3 · price: Represents the issuance of common stock upon the vesting and settlement of outstanding restricted stock units for the restricted stock units granted on November 21, 2023. Read SEC document |
| May 06, 2024 Filed May 8, 2024 22:36 UTC |
Finley John DavidDirector · CEO, CFO, Director
|
Tax withholdingCommon Stock, par value $0.01 | 67 | $8.46 | $566.82 |
DisclosureSEC source: 0001493152-24-018282 · ownership.xml · nonDerivative · entry 2 Finley John David · CIK 0001851034 · Director · CEO, CFO, Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,621 F2 · security: Represents shares withheld to cover tax withholding obligations in connection with the vesting and settlement of the restricted stock units referenced in footnote 1. F2 · shares: Represents shares withheld to cover tax withholding obligations in connection with the vesting and settlement of the restricted stock units referenced in footnote 1. Read SEC document |
| May 06, 2024 Filed May 8, 2024 22:36 UTC |
Finley John DavidDirector · CEO, CFO, Director
|
Exercise / conversionCommon Stock, par value $0.01 | 232 | $0.00 | $0.00 |
DisclosureSEC source: 0001493152-24-018282 · ownership.xml · nonDerivative · entry 1 Finley John David · CIK 0001851034 · Director · CEO, CFO, Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,688 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: Represents the issuance of common stock upon the vesting and settlement of outstanding restricted stock units for the restricted stock units granted on June 8, 2023. F1 · shares: Represents the issuance of common stock upon the vesting and settlement of outstanding restricted stock units for the restricted stock units granted on June 8, 2023. F1 · price: Represents the issuance of common stock upon the vesting and settlement of outstanding restricted stock units for the restricted stock units granted on June 8, 2023. Read SEC document |
| May 06, 2024 Filed May 8, 2024 22:37 UTC |
Jones Mitchell LawrenceCEO, CFO, Director
|
Exercise / conversionRestricted Stock Units · Derivative | 156 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001493152-24-018284 · ownership.xml · derivative · entry 6 Jones Mitchell Lawrence · CIK 0001993292 · CEO, CFO, Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,555 Underlying: Common Stock · 156 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F7 · security: This restricted stock unit was granted on November 21, 2023, and 156 restricted stock units subject to the award vested on May 6, 2024, and an additional 1,555 restricted stock units will vest in equal quarterly installments over the remaining portion of the three-year period from the grant date, subject to Reporting Person continuing to be a service provider to Issuer at the time of vesting. F7 · derivative.exercise_price: This restricted stock unit was granted on November 21, 2023, and 156 restricted stock units subject to the award vested on May 6, 2024, and an additional 1,555 restricted stock units will vest in equal quarterly installments over the remaining portion of the three-year period from the grant date, subject to Reporting Person continuing to be a service provider to Issuer at the time of vesting. F7 · price: This restricted stock unit was granted on November 21, 2023, and 156 restricted stock units subject to the award vested on May 6, 2024, and an additional 1,555 restricted stock units will vest in equal quarterly installments over the remaining portion of the three-year period from the grant date, subject to Reporting Person continuing to be a service provider to Issuer at the time of vesting. F5 · derivative.exercise_date: Each restricted stock unit represents the right to receive, at settlement, one share of common stock. F5 · derivative.expiration_date: Each restricted stock unit represents the right to receive, at settlement, one share of common stock. Read SEC document |
| May 06, 2024 Filed May 8, 2024 22:37 UTC |
Jones Mitchell LawrenceCEO, CFO, Director
|
Exercise / conversionRestricted Stock Units · Derivative | 304 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001493152-24-018284 · ownership.xml · derivative · entry 5 Jones Mitchell Lawrence · CIK 0001993292 · CEO, CFO, Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,735 Underlying: Common Stock · 304 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · security: This restricted stock unit was granted on September 5, 2023, and 304 restricted stock units subject to the award vested on May 6, 2024, and an additional 2,735 restricted stock units will vest in equal quarterly installments over the remaining portion of the three-year period from the grant date, subject to Reporting Person continuing to be a service provider to Issuer at the time of vesting. F6 · derivative.exercise_price: This restricted stock unit was granted on September 5, 2023, and 304 restricted stock units subject to the award vested on May 6, 2024, and an additional 2,735 restricted stock units will vest in equal quarterly installments over the remaining portion of the three-year period from the grant date, subject to Reporting Person continuing to be a service provider to Issuer at the time of vesting. F6 · price: This restricted stock unit was granted on September 5, 2023, and 304 restricted stock units subject to the award vested on May 6, 2024, and an additional 2,735 restricted stock units will vest in equal quarterly installments over the remaining portion of the three-year period from the grant date, subject to Reporting Person continuing to be a service provider to Issuer at the time of vesting. F5 · derivative.exercise_date: Each restricted stock unit represents the right to receive, at settlement, one share of common stock. F5 · derivative.expiration_date: Each restricted stock unit represents the right to receive, at settlement, one share of common stock. Read SEC document |
| May 06, 2024 Filed May 8, 2024 22:37 UTC |
Jones Mitchell LawrenceCEO, CFO, Director
|
Tax withholdingCommon Stock, par value $0.01 | 47 | $8.46 | $397.62 |
DisclosureSEC source: 0001493152-24-018284 · ownership.xml · nonDerivative · entry 4 Jones Mitchell Lawrence · CIK 0001993292 · CEO, CFO, Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 833 F4 · security: Represents shares withheld to cover tax withholding obligations in connection with the vesting and settlement of the restricted stock units referenced in footnote 3. F4 · shares: Represents shares withheld to cover tax withholding obligations in connection with the vesting and settlement of the restricted stock units referenced in footnote 3. Read SEC document |
| May 06, 2024 Filed May 8, 2024 22:37 UTC |
Jones Mitchell LawrenceCEO, CFO, Director
|
Exercise / conversionCommon Stock, par value $0.01 | 156 | $0.00 | $0.00 |
DisclosureSEC source: 0001493152-24-018284 · ownership.xml · nonDerivative · entry 3 Jones Mitchell Lawrence · CIK 0001993292 · CEO, CFO, Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 880 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · security: Represents the issuance of common stock upon the vesting and settlement of outstanding restricted stock units for the restricted stock units granted on November 21, 2023. F3 · shares: Represents the issuance of common stock upon the vesting and settlement of outstanding restricted stock units for the restricted stock units granted on November 21, 2023. F3 · price: Represents the issuance of common stock upon the vesting and settlement of outstanding restricted stock units for the restricted stock units granted on November 21, 2023. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.